background: When a small gestational sac with no visible embryo is seen at an early pregnancy ultrasound scan, the clinician cannot distinguish a viable from a non-viable pregnancy. A test for the prediction of early pregnancy viability at the initial visit was developed in 2003. Maternal age, gestational sac diameter (GSD) and serum progesterone levels were used in a logistic regression model to create an algorithm for estimation of the probability of a viable pregnancy. The objective of this study was to assess how well the test performed in routine clinical practice.
Introduction
Transvaginal ultrasound scanning enables the visualization of very early pregnancies prior to there being a visible embryo. Counselling women who present with symptoms and who are found to have a small, apparently empty gestational sac on scan is difficult, as no conclusive diagnosis can be given at the first visit; it may be that the pregnancy is ongoing, but is of 4-5 weeks gestational age and therefore too early to identify an embryo, or it may be a failing pregnancy destined to miscarry. These pregnancies are defined in our unit as 'early intrauterine pregnancies' (EIUPs). Alternative nomenclature used in some Early Pregnancy Units (EPUs) is 'intrauterine pregnancy of uncertain viability' (Royal College of Obstetricians and Gynaecologists, 2006) . According to the guidelines published by the Royal College of Radiologists and the Royal College of Obstetricians and Gynaecologists, the ultrasound diagnosis of early embryonic demise should only be made after an interval of at least a week (Hately et al., 1995) . By this time, further growth in the gestational sac or appearance of contents such as a yolk sac or embryo should have occurred if the pregnancy is ongoing. This period of uncertainty until a conclusive diagnosis can be reached may cause anxiety for the couple.
Previously, a logistic regression model was created to help in differentiating between ongoing pregnancies and non-viable pregnancies at the initial visit (Elson et al., 2003) . The model was based on the results of a prospective observational study of 200 women in our EPU. In that study, women were included when there was a gestational sac measuring ,20 mm mean diameter with no visible embryo seen on transvaginal ultrasound. Clinical, ultrasound and biochemical parameters were recorded and the women were managed expectantly until the pregnancy viability was conclusively established by ultrasound. There were significant differences between the presence and absence of vaginal bleeding, gestational age, mean gestational sac diameter (GSD) and progesterone levels between viable and non-viable pregnancies, but no difference in hCG levels. Only three of these variables were found to be independent with statistically significant coefficients in a multivariate logistic regression analysis. The resulting model combined maternal age with mean GSD and serum progesterone in an algorithm to predict early pregnancy viability. The model could be used to express as a percentage, the likelihood of the pregnancy being ongoing.
We have offered the use of this model as an optional test to predict viability to women with EIUP since 2003. The aim of the present study was to evaluate how the model has performed in clinical practice since introduced into routine use in our EPU.
Materials and Methods
This was a retrospective analysis of data collected contemporaneously over a 6-year period from 1January 2003 to 31 December 2008. The study was conducted in an inner city teaching hospital. Women were referred to our EPU by their General Practitioner or emergency department doctor or they self-referred. Women were not seen in the EPU as part of their routine antenatal care; the EPU service is for the assessment of women with symptoms such as abdominal pain, bleeding, hyperemesis or for asymptomatic women at risk of complications such as those with a previous ectopic pregnancy or history of recurrent miscarriages. The patient's history and demographic data were documented on a computer database (PIA Fetal Database, Viewpoint Bildverarbeitung GmbH, Munich, Germany) . Transvaginal ultrasounds (GE Voluson 730 expert, Aloka 5500) were performed by the attending clinicians who were specialist trainees in obstetrics and gynaecology. Scans showing miscarriage, pregnancy of unknown location or ectopic pregnancy were verified by a second examiner, the senior Gynaecologist supervising the clinic. The gestational sac was measured from the inner edges of trophoblast in three orthogonal planes and the mean of these three measurements were recorded as mean GSD. The presence of a yolk sac, appearance of the uterus, ovaries, pouch of Douglas and ultrasound images were recorded on the same database.
Women with a positive urine pregnancy test (Clearview HCG II) who had conceived spontaneously and had a single intrauterine gestational sac of ,20 mm mean GSD with no visible embryo on their first ultrasound scan were eligible to have the test performed. A yolk sac was not considered to be a visible embryo; so these women were included. Exclusion criteria were assisted conception, multiple pregnancy, use of exogenous progesterone and intention to terminate the pregnancy. Women who accepted the test had a serum sample taken to estimate progesterone level and serum b-hCG using an automated immunoassay technique (Advia Centaur Immunoassay system, Siemens AG, Germany). The probability of viability was calculated for each patient using the following formula:
, where z ¼ (6.091 × ln progesterone) 2 (0.159 × mean GSD) 2 (0.164 × maternal age) 2 17.435. Women were informed of the test result by telephone later the same day.
Follow-up was arranged for all women after 1 -2 weeks depending on mean GSD and subsequently for the first trimester combined screening test between 11 and 14 weeks gestation if the pregnancy was ongoing. The final diagnosis of a viable pregnancy was made at the 11 -14 week scan. Miscarriage was defined as the absence of a previously visible gestational sac, when the gestational sac remained without an embryo or embryonic cardiac activity ceased within the first trimester. Pregnancies that were viable at the initial follow-up but miscarried later in the first trimester were therefore counted as miscarriages.
Data were exported from the Viewpoint database into Excel (Microsoft w Office 2003) and statistical analyses were made with SPSS Version 17 (SPSS Inc., Chicago, IL, USA) and Graphpad Prism 5 (Graphpad Software, San Diego, CA, USA). The means of normally distributed data were compared with the independent two sample t-test. Nonparametrically distributed data were compared with the Mann-Whitney U-test and categorical data with the x 2 test with Yates correction. The accuracy of the logistic regression model and individual diagnostic variables in predicting early pregnancy viability were described using the receiver operating characteristics (ROC) curves. For each parameter, we identified the cut-off level that yielded the highest possible combination of sensitivity and specificity and the clinically optimal cut-off levels.
Results
During the study period, 25 928 early pregnancies were examined. At presentation, 13 464 (51.9%) had the diagnosis of a viable pregnancy, 6023 (23.2 %) had an EIUP, 2967 (11.4%) had a pregnancy of unknown location, 2646 (10.2 %) had a miscarriage and 828 (3.2%) had an ectopic pregnancy. Of the 6023 EIUPs, we identified 5163 patients who would have been eligible to have the test performed. Four hundred and eighty women had the test performed over the study period. On examining the clinical records, eight of these women should not have had the test performed; four had a visible embryo and four had a GSD .20 mm. Of the 472 who were eligible, 67 were lost to follow-up due to termination of pregnancy or nonattendance; there were two monochorionic twin pregnancies and in three women the serum progesterone level was not taken on the same day as the scan was performed. Therefore, 472/5163 (9.1%) of eligible women had the test performed, but the inclusion criteria were met and the data were complete in 400/472 (84.7%). Due to the low uptake of the test in clinical practice, we compared the clinical parameters of the women with EIUP who met the eligibility criteria but did not have the test with those in the clinical study population (Table I) . Women included in the study were significantly older, more often had a history of first trimester miscarriage, were at a more advanced gestational age and had smaller gestational sacs than those not having the test. Women having the test performed were also less likely to have had a yolk sac seen on scan. Vaginal bleeding was the most frequent primary indication for examination in both groups, and was significantly more common in the women having the test performed.
Of the 400 women in the study population, 199 [49.8%; 95% confidence interval (CI), 44.8-54.6%] had ongoing pregnancies and 201 (50.3%; 95% CI, 45.3-55.1%) had non-viable pregnancies at follow-up. Of the non-viable pregnancies, 77 (38.3%) were diagnosed on follow-up as delayed miscarriages, 47 (23.4%) as incomplete miscarriages and 77(38.3%) as complete miscarriages. A comparison of the individual clinical, ultrasound and biochemical findings of viable and non-viable pregnancies is presented in Table II . The women with viable pregnancies were younger, presented earlier, less likely to present with vaginal bleeding and more likely to present with isolated abdominal pain than those with non-viable pregnancies. They also had significantly higher serum b-hCG levels and their median progesterone level was twice as high as that in non-viable pregnancies.
Women with a viable pregnancy were also less likely to have had a previous miscarriage. A yolk sac was present in about one-third of the pregnancies and the proportion did not differ significantly between viable and non-viable pregnancies.
The results of the ROC curve analyses for the logistic regression model and individual parameters are reported in Table III and Figs 1  and 2 . Using single parameters, a sensitivity of 100% (95% CI, 98.2 -100.0%) and a specificity of 30.9 % (24.5-37.7%) were reached using serum progesterone alone. To reach this level of sensitivity, the cut-off level of serum progesterone was 22.5 nmol/l (i.e. the lowest serum progesterone level seen in a pregnancy that was viable was 23 nmol/l). Using hCG alone, all pregnancies with a visible gestational sac ended with miscarriage when the serum hCG was ,465 IU/l giving a cut-off for a sensitivity of 100% (95% CI, 97.7% -100.0) and specificity of 14.1% (95% CI, 9.9 -19.7%). Normally distributed data given as mean (standard deviation), non-parametrically distributed data # given as median (25th to 75th interquartile range), discrete data shown as percentage (%) of each population.
We used the ROC curves to determine the optimum cut-off level for each of the parameters. The area under the curve of the logistic regression model was significantly greater than any of the single parameters. The model reached its highest sum of sensitivity and specificity to differentiate between viable and non-viable pregnancy at a cut-off level of 20% probability. The model calculated probability of viability of ,20% in 131 pregnancies. Four of these pregnancies were subsequently found to be viable pregnancies and were therefore false negatives. If the model were to be used as a simple test for viability, to avoid the risk of diagnosing viable pregnancies as non-viable, the cut-off value for the logistic regression model could be reduced to 4.35%, resulting in a sensitivity of 100% (95% CI, 98.2-100.0%) and a specificity of 49.8% (95% CI, 42.6 -56.9%, i.e. no pregnancy in the study population with a probability of ,4.35% was viable).
Discussion
The logistic regression model can be applied in clinical practice to predict, with a reasonable degree of accuracy, the viability of pregnancies when the viability is uncertain on the initial ultrasound scan. The study confirmed that the logistic regression model performed better than any of the individual parameters tested when applied to a clinical population, as it had done in the original study. However, the model did not perform as well in clinical practice as reported in the original study population (Table III) A comparison of the population variables in our clinical population and the previous study can be seen in Table IV . There were a significantly higher proportion of miscarriages in the clinical population although the maternal age and percentage of women with vaginal bleeding were not significantly different. Another reason for the lower performance of the model could be the longer follow-up in the clinical study population. In the original study, the maximum follow-up was 2 weeks. Pregnancies that were viable on the initial follow-up and miscarried later in the first trimester could have counted in the original study as viable. In the clinical population, 21 pregnancies (5.3%) were viable on initial follow-up and miscarried later in the first trimester. However, if we defined these pregnancies as viable, the area under the curve would only increase to 0.86 (CI 0.80 -0.90).
The gestational age at presentation was greater and the mean GSD was smaller than in the original study. The discrepancy between gestational age and ultrasound findings can reflect early embryonic growth restriction and is a predictor of subsequent miscarriage (Donald et al., 1972; Robinson, 1975; Choong et al., 2003; Bottomley et al., 2009) . This implies that clinicians were either more likely to recommend the test, or women were more likely to accept the test, if the risk of miscarriage was perceived to be high based on a discrepancy between the dates and the ultrasound findings.
The median hCG and progesterone levels were significantly lower in both the viable and non-viable pregnancies in this study than in the previous study. The laboratory assay system for progesterone was changed between the original study and the introduction of the test into clinical practice and progesterone assays may show up to 20% variation between manufacturers (Chetty and Elson, 2007) ; so this may account for some of the variation. The gestational age at presentation was higher in the clinical population; so it may be that the hCG and progesterone levels were in decline in those pregnancies that were failing, but this could not provide an explanation for the lower levels in those that were viable.
Elson et al. suggested using a cut-off level for the logistic regression model of 10% probability of a viable pregnancy. At a cut-off level of 10%, we achieved a sensitivity of 99.0% (95% CI, 96.42 -99.88%) and a specificity of 56.7% (95% CI, 49.56 -63.67%) with a positive predictive value of 69.37% and a negative predictive value of 98.27%. This compares with a sensitivity of 99.2% (95% CI, 95.8 -99.97%) and a specificity of 70.7% (95% CI, 61.3 -78.9%) in their study. Due to the lower specificity in our study, the false positive rate was higher at the same cut-off than in the original study; i.e. there were more miscarriages in the group predicted to be viable. Again, this is likely to reflect the higher pre-test probability of miscarriage in the clinical population. Our clinical population contained a high proportion (9%) of women with three or more previous miscarriages, given that the background incidence of recurrent miscarriage is estimated as 1% (Brigham et al., 1999) . By excluding women with recurrent miscarriages from the analysis, the area under the curve of the logistic regression model can be increased to 0.88, but this is still not as good a performance as in the original study population.
Overall, were unable to establish whether the test performed less well due to a problem inherent in the model itself or due to differences between the clinical and study populations. A limitation of the study is that only 9.1% of eligible women had the test performed. The comparison of the clinical study population with the general population of women with EIUP during the study period showed that the women who formed the clinical study group were not representative of the general EIUP population and that as suspected, they were more likely to be at risk of miscarriage due to increased age, a history of previous first trimester miscarriage, vaginal bleeding or a smaller than expected gestational sac. We accept that this was a potential source of bias that would have lowered the performance of this test for viability, due to a lower prevalence of the index condition in the clinical study group. The maternal age of women in the clinical study did not differ from the original study, which suggests that older women were also more likely to participate in the original study, as the mean maternal age has not declined in our general EPU population since that time.
We looked at whether the experience of the examiners performing the assessment influenced whether the test was performed (Table 1 Non-parametrically distributed data given as median (25th -75th interquartile range).
Viability of early pregnancies and found that the test was more likely to have been used when a senior doctor was the primary examiner. This implied that the more junior doctors were either not offering the test or not counselling the women so that they chose to have the test performed. This study demonstrates the importance of assessing how well an intervention designed in a research setting translates into clinical practice, where the population and levels of clinical counselling may differ. A variety of alternative sonographic and biochemical markers have been used to attempt to differentiate ongoing early pregnancies from those destined to miscarry. An irregular gestational sac or abnormal placenta, an empty amniotic sac (McKenna et al., 1995) or a collapsed or dilated yolk sac (Lindsay et al., 1992) are all markers of a failing pregnancy. However, with small gestational sacs ,20 mm diameter, these markers cannot be taken in isolation to definitively diagnose miscarriage and, in our study, the presence and absence of a yolk sac had no predictive value for pregnancy viability. The number of standard deviations from the expected mean GSD has been suggested as the most powerful independent predictor of pregnancy failure, though this was based on a relatively small study of 50 patients and cannot be used in women with uncertain or unknown menstrual dates (Falco et al., 2003) . Bottomley et al. recently described logistic regression models and a scoring system to predict viability in EIUPs both in the short-term and at the end of the first trimester (Bottomley et al., 2011) . Their models were developed on a data set of 329 pregnancies and incorporated clinical and ultrasound parameters, but no measurement of serum progesterone. Their logistic regression model showed a performance similar to ours in their test population of 164 pregnancies, but it has not yet been tested in clinical practice. The Bottomley model would be cheaper and less invasive if it performs well in clinical practice.
Serum biochemical markers have been used to predict viability alone or in combination. They have been studied in a variety of populations either defined by clinical symptoms or by ultrasound findings. Most studies attempting to use hCG have not correlated levels with ultrasound findings and like this study, none have found a single hCG measurement to be a useful predictor of viability. Serial hCG measurements have the disadvantage of requiring a second hospital visit for the second hCG level after 48 h and have not been applied to a population of women with EIUP. In a study of women in whom the pregnancy could not be located by ultrasound, the slowest rise predicted to be compatible with a viable pregnancy was 53% given 99% Cls (Barnhart et al., 2004) . Progesterone estimation has the advantage of only requiring a single measurement. Most studies using a combination of markers have found that progesterone alone performs almost equally as well (Plante et al., 2008 ). However, the lowest level that has been reported with a viable pregnancy is 5.1 ng/ml (;16 nmol/l) (Stovall et al., 1992) and women with pregnancies of unknown location may have ongoing pregnancies with progesterone levels ,10 nmol/l at presentation (Day et al., 2009) ; so there is no cut-off progesterone level that is absolutely incompatible with a viable pregnancy.
The advantage of using this logistic regression model is that the result can be given as the likelihood that the pregnancy will be viable, expressed as a percentage, rather than using the statistically defined cut-offs. This conveys a degree of uncertainty associated with the test rather than giving a categorical positive or negative result and the calculation can be easily performed using an excel programme on a computer desktop. Given the benign course of first trimester miscarriage, we would not advocate surgical or medical intervention for miscarriage based on the application of this logistic regression model as there exists a very small risk of inadvertently terminating a potentially viable pregnancy. Having confirmed that the test is sufficiently accurate when used in clinical practice, but potentially underutilized, future research should focus on establishing whether there is any real benefit to women in having the test performed, either using our progesterone-based model or that of Bottomley et al. Knowing that a pregnancy has very low odds of being viable may help women to be prepared for the spontaneous miscarriage that may occur in the interval between ultrasound examinations (Wieringa-de Waard et al., 2002) or may allow the provisional scheduling of an evacuation of retained products of conception for soon after her repeat scan. Women with good odds of the pregnancy being viable may have reduced levels of anxiety while waiting, but there will remain a number of women who have more equivocal results. Future studies are needed to establish which is the best test to use, how useful women perceive the tests to be and whether they derive any psychological benefit from having the test performed.
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